Skip to main content
Equibles

Andrew Benson

Co-Diagnostics, Inc. (CODX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Co-Diagnostics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CODX alerts

About Andrew Benson

Andrew Benson has spoken on 21 earnings calls across 1 company, most recently for Co-Diagnostics, Inc. on August 13, 2026. Co-Diagnostics, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Co-Diagnostics, Inc. includes Dwight H Egan (CEO), Brian Brown (CFO), Brian L. Brown, CPA (CFO) and 6 others.

Andrew Benson on recent calls

“On the line today from CoDiagnostics, we have Dwight Egan, Chief Executive Officer, and Brian Brown, Chief Financial Officer. Earlier today, CoDiagnostics released financial results from the second quarter ended June 30, 2026.”
Head of Investor Relations, Co-Diagnostics, Inc. Second Quarter 2026 Earnings Webcast ·
“On the line today from CoDiagnostics, we have Dwight Egan, Chief Executive Officer, and Brian Brown, Chief Financial Officer. Earlier today, CoDiagnostics released financial results from the first quarter ended March 31, 2026.”
Head of Investor Relations, Co-Diagnostics, Inc. Q1 FY2026 Earnings Call ·
“On the line today from CoDiagnostics, we have Dwight Egan, Chief Executive Officer, and Brian Brown, Chief Financial Officer. Earlier today, CoDiagnostics released financial results from the fourth quarter and full year ended December 31st, 2025.”
Head of Investor Relations, Co-Diagnostics, Inc. Q4 FY2025 Earnings Call ·
“On the line today from Co-Diagnostics, we have Dwight Egan, Chief Executive Officer; and Brian Brown, Chief Financial Officer. Earlier today, Co-Diagnostics released financial results from the third quarter ended September 30, 2025.”
Head of Investor Relations, Co-Diagnostics, Inc. Q3 FY2025 Earnings Call ·
“On the line today from Co-Diagnostics, we have Dwight Egan, Chief Executive Officer; and Brian Brown, Chief Financial Officer. Earlier today, Co-Diagnostics released financial results from the second quarter ended June 30, 2025.”
Head of Investor Relations, Co-Diagnostics, Inc. Q2 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Co-Diagnostics, Inc.

Recent activity

Show 9 earlier activities